What we say. What we can prove. What we won't claim.
Corporate ownership, commercial relationships, evidence-governance disclosures and communication principles for AUREVIA, NuraProof and AES.
Ownership
AES is the research and scientific-affairs division of the AUREVIA group. AES does not represent itself as an independent validator of AUREVIA products.
Commercial relationships
AUREVIA discloses whether it owns, distributes exclusively, retails via third parties, has an affiliate relationship, or has no commercial relationship with each listed product.
Evidence classifications
AES uses internal evidence classifications — Established, Supported, Emerging, Mechanistic, Not Established — which are not clinical grades.
Endorsements
AUREVIA does not imply endorsement by regulators, universities, clinicians or laboratories. Partners appear only when a written agreement is on file.
Real-world data
Voluntary NuraProof observational data is analysed only under explicit consent, with de-identification and disclosed commercial interests.
Investor communications
Nothing on this website constitutes an offer to sell or a solicitation of an offer to buy any security.